Leaflet COLDREX MAX COLD AND COUGH capsules

Indicated for: productive cough; expectoration

Route of administration: oral

Substance: guaifenesin + phenylephrine (expectorant + adrenergic decongestant)

ATC: N02BE51 (Nervous system | Other analgesics and antipyretics | Anilides)

Precautions:
Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

The combination of guaifenesin and phenylephrine is used to relieve cold and flu symptoms, including nasal congestion and productive cough. It combines an expectorant with a nasal decongestant.

Guaifenesin helps thin mucus, making it easier to expel, while phenylephrine reduces nasal congestion by constricting blood vessels in the nasal lining.

This combination is generally well-tolerated but may cause side effects such as dizziness, nausea, insomnia, or increased blood pressure. In rare cases, allergic reactions may occur.

It is important to follow the dosage instructions and avoid long-term use without a doctor's recommendation. Consult a specialist if symptoms persist or worsen.

General data about COLDREX MAX COLD AND COUGH

  • Substance: guaifenesin + phenylephrine
  • Date of latest medicines list: 01-04-2022
  • Product code: W68509001
  • Pharmaceutical form: capsules
  • Quantity: 8
  • Product type: Generic medicine
  • Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

  • Manufacturer: OMEGA PHARMA INTERNATIONAL NV - BELGIA
  • Holder: HIPOCRATE 2000 S.R.L. - ROMANIA
  • Number: 14162/2021/01
  • Shelf life: 3 years

Combinations with other substances